Eliya Yehuda 4
4 · Raphael Pharmaceutical Inc. · Filed Mar 12, 2025
Insider Transaction Report
Form 4
Eliya Yehuda
Director
Transactions
- Award
Warrant to purchase Common Stock
2025-03-10+200,000→ 200,000 totalExercise: $1.00Exp: 2026-03-10→ Common Stock (200,000 underlying) - Expiration
Warrant to purchase Common Stock
2022-05-12−202,000→ 0 totalExercise: $1.12Exp: 2024-05-12→ Common Stock (202,000 underlying)
Footnotes (2)
- [F1]200,000 warrants to purchase Common Stock of the issuer were received as compensation for the reporting person's service as a director of the issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 10, 2025. The Warrants are exercisable immediately and will expire on March 10, 2026.
- [F2]202,000 warrants to purchase Common Stock of the issuer expired on May 12, 2024, and are no longer beneficially owned by the reporting person.